微信直播

Richard Tuli:放射治疗——充满活力、前景无限

Published at: 2015年第1卷第S1期

王天柳
关键词:

编者按:由上海交通大学医学院附属新华医院主办的第八届新华国际外科论坛于2017年11月17日-18日在上海圆满召开。会议期间,AME编辑很荣幸地采访了来自Cedars-Sinai Medical Center的胰腺癌专家Richard Tuli 。在此,编辑与大家一起分享Tuli教授关于胰腺癌放射治疗的精彩见解。

人物聚焦:Richard Tuli

Dr. Richard Tuli is a radiation oncology specialist in west Hollywood, California. He graduated with honors from Jefferson Medical College Of Thomas Jefferson University in 2006. Having more than 11 years of diverse experiences, especially in radiation oncology, Dr. Richard Tuli affiliates with Cedars-sinai Medical Center, and cooperates with other doctors and specialists in many medical groups including Cedars-sinai Medical Center. His research interests include investigating novel radiotherapy techniques to improve outcomes and minimize toxicity, and identifying radio-sensitizing agents for treating cancer.

Current research is directed toward PARP inhibitors, immunotherapies and other novel drugs in combination with radiation. His awards include the ASCO Cancer Foundation Merit Award, AACR Scholar-in-Training Award and Hyman Menduke Research Prize. In addition to presenting his research at numerous national and international conferences, Tuli serves as a manuscript reviewer for peer-reviewed journals. He is one of the guest editors of AME publishing company.

会中,Tuli教授(图1)就“Advances in radiotherapy and radiotherapy/drug combination for Pancreatic and GI malignancies”的话题作了精彩演讲。他用数年的临床实验数据和图表进行对比分析,介绍了放疗治疗胰腺癌的最新进展。在美国,辅助性的CRT(cathode ray tube,阴极射线管)仍然是治疗胰腺癌的首选方案。对于病情趋于稳定的局部晚期胰腺癌患者和Burkitt 淋巴瘤患者,医生会首先采取化疗手段,然后采用SBRT(stereotactic body radiotherapy,立体定向放射治疗)进行综合治疗。

图1. Tuli教授在新华会议中作精彩演讲

会后,我们很荣幸邀请到Tuli教授接受采访。Tuli教授在采访中一直强调,作为医生,他还有许多未竟的工作要不断努力,这体现了他作为一名学者的谦虚和谨慎。Tuli教授与我们分享了他选择研究放疗的原因:放疗是一门充满活力的专业,其需要物理学、医学物理学和临床肿瘤学知识的综合运用,这些都使之成为一个在探索过程中令人兴奋的领域。Tuli教授还透露他之所以不断参与研讨会议的原因就在于希望有更多外科医生能够相信放疗在肿瘤治疗中是有益的。他认为放疗有“无侵略性、无需开刀、无需注射”的优点,会在针对多种癌症的治疗中起到很好的效果。

此外,Tuli教授也提到了放疗治疗过程的一些困难,例如患者需要每日接受放疗并持续一周到六周的时间,这是一个令患者很难坚持的过程。基于此,Tuli教授表示,他以及他的团队会在今后的研究中不断努力,争取为更多胰腺癌患者带来新的希望,使他们更好地获益。

欲知更多精彩内容,敬请点击下方视频。


采访问题

1. Could you please share some latest advances in radiotherapy or radiotherapy techniques for pancreatic cancer?

2. Would you like to share with us why you are interested in radiation oncology, a field even not well understood by some surgeons?

3. Your current research is directed toward PARP inhibitors, immunotherapies and other novel drugs in combination with radiation. Could you share what you achieved in the field?

4. What are implications for radiotherapy for pancreatic cancer the next century in your view?


采写编辑:王天柳,第二届追梦计划见习编辑

视频编辑:麦雪芳,AME Publishing Company

学术审核:张开平,AME Publishing Company

责任编辑:徐畅、许梦杨,AME Publishing Compa

comments powered by Disqus

附件